The results were combined using Rubins rule [16]
The article lists baseline gastrointestinal symptoms, bile acid malabsorption status, current medications, and any history of pancreatitis or acute abdomen as the pre-treatment assessment
The availability of compounded GLP-1s without a prescription (illicit manufacturing and distribution) is a serious issue
March 5, 2026- FDA bashes Novo for not reporting severe adverse events Novo Nordisk, is taking intense criticism from the FDA, Center for Drug Evaluation and Research (CDER), for not properly reporting alleged adverse events linked to its GLP-1 drugs, including a death
Cognitive function was measured using the Y-Maze spontaneous alternation test, a reliable indicator of working memory